SCHEMBL6711225

SCHEMBL6711225

O=CCCOCCc1cccc2ccccc12

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 2/20 0.43
NQO2 P16083 1/20 0.42
FFAR4 Q5NUL3 1/20 0.41
CASP1 P29466 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
TDP1 Q9NUW8 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2C19 P33261 2/20 0.41
CYP2C9 P11712 1/20 0.41
ACP3 P15309 1/20 0.40
ADRB2 P07550 1/20 0.40
ADRB1 P08588 1/20 0.40
CDYL Q9Y232 1/20 0.40
DAO P14920 1/20 0.39
CYP2D6 P10635 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4528236 0.98 MTNR1A (0.42) MTNR1ANQO2FFAR4CASP1NPC1
SCHEMBL586305 0.86 CYP1A2 (0.52) MTNR1ANQO2TDP1CYP1A2CYP2C19
SCHEMBL4514641 0.86 ADRB2 (0.46) MTNR1ANQO2FFAR4CASP1NPC1
SCHEMBL6538980 0.85 NPC1 (0.49) NPC1RAB9ATDP1CYP1A2CYP2C19
SCHEMBL143458 0.83 MTNR1A (0.49) MTNR1ANQO2NPC1RAB9ATDP1
SCHEMBL143128 0.80 MTNR1A (0.47) MTNR1ANQO2TDP1CYP1A2CYP2C19
SCHEMBL11052717 0.78 CYP1A2 (0.46) MTNR1ANQO2TDP1KDM4ECYP1A2
SCHEMBL3113301 0.78 CYP1A2 (0.44) MTNR1ANQO2FFAR4TDP1CYP1A2
SCHEMBL4521520 0.78 MTNR1A (0.45) MTNR1ANQO2FFAR4TDP1KDM4E
SCHEMBL3225216 0.78 MTNR1A (0.45) MTNR1ANQO2TDP1CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1392315-A1 METHODS OF TREATING ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2004-03-03 EP disclosed
WO-2002100410-A1 METHODS OF TREATING ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2002-12-19 WO disclosed